New drugs under development for Alzheimer’s disease
Lezanne Ooi(University of Wollongong), Gerald Münch(Camden and Campbelltown Hospitals), Rachel Debono(Western Sydney University), Kirubakaran Shanmugam(Western Sydney University), Mili Patel
Cited by 0
Related Papers
TRPV3 is a temperature-sensitive vanilloid receptor-like protein
|Nature|2002|851
Chromatin crosstalk in development and disease: lessons from REST
|Nature Reviews Genetics|2007|404
Neuronal hyperexcitability in Alzheimer’s disease: what are the drivers behind this aberrant phenotype?
|Translational Psychiatry|2022|392
The acute nociceptive signals induced by bradykinin in rat sensory neurons are mediated by inhibition of M-type K+ channels and activation of Ca2+-activated Cl– channels
|Journal of Clinical Investigation|2010|291